October 29, 2020, 3:00pm EST
The process of bringing a new drug or therapy to market poses a unique set of challenges.
A data-driven approach can fuel your team’s early stage strategy during phase III clinical trials, registration/PDUFA set, planning sales territories, and building unbranded awareness.
Hosted on October 29th , tune in to the replay to hear how data can be used to manage three common challenges during launch planning:
Todd has spent his executive leadership career building healthcare provider and patient analytics. He has grown powerful data and professional services teams at Definitive Healthcare and DRG, and has helped thousands of leading life sciences and technology companies build their commercialization strategies through a deep understanding of the healthcare facilities, physicians, and patient landscape. With more than 20 years of experience in the hospital equipment, medical device, clinical trials, technology, and data and analytics fields, Todd brings a complete picture to his analysis and discussions
Definitive Healthcare is the number one healthcare data and analytics platform, delivering information on every care provider in the U.S. Based on 3 billion+ medical and Rx claims, the platform empowers users to analyze referral patterns, financial metrics, clinical data, HCAHPs scores, and other data on hospitals, physicians, medical groups, IDNs, surgery centers, long-term care facilities, and others. Request a free trial to explore the platform.